SCHEMBL13601437

SCHEMBL13601437

CC1CCN(CCC(=O)OCC(=O)N(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.42
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.38
MEN1 O00255 2/20 0.37
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
DRD1 P21728 1/20 0.37
ADRA1A P35348 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12773999 0.86 SMN1; SMN2 (0.40) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL13601361 0.85 MAPT (0.38) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL13601625 0.83 TP53 (0.43) SMN1; SMN2KMT2AALDH1A1MAPTTP53
SCHEMBL13601396 0.83 POLB (0.54) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL27976667 0.82 POLB (0.57) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL12774126 0.82 TP53 (0.42) SMN1; SMN2KMT2AALDH1A1MAPTTP53
SCHEMBL13601525 0.81 MEN1 (0.38) POLBSMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL12881444 0.80 TP53 (0.42) SMN1; SMN2KMT2AALDH1A1MAPTTP53
SCHEMBL13601415 0.79 POLB (0.48) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL12842063 0.79 GNAI3 (0.41) SMN1; SMN2MAPTLMNAKCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed